Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

Sponsor
Satish R. Raj (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00692471
Collaborator
National Center for Research Resources (NCRR) (NIH)
100
1
198
0.5

Study Details

Study Description

Brief Summary

We propose to use actigraphy (measured by activity watches) as a tool to quantify sleep disturbances in patients with orthostatic intolerance compared with healthy control subjects. In this pilot study, we will test the null hypothesis (Ho) that there are no differences in the sleep quality between patients with orthostatic intolerance and healthy control subjects.

Condition or Disease Intervention/Treatment Phase
  • Device: Actigraphy Watch (motion sensors) with light sensors - ActiWatch from Minimitter

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Assessment of Objective Sleep Disturbances in Orthostatic Intolerance Using Actigraphy
Study Start Date :
Jun 1, 2008
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
1

Patients meeting the diagnostic criteria for the Postural Tachycardia Syndrome, a form of Orthostatic Intolerance

Device: Actigraphy Watch (motion sensors) with light sensors - ActiWatch from Minimitter
Watch to be worn on wrist for 7 days (except in water) that will measure activity/movement.
Other Names:
  • ActiWatch from Minimitter
  • 2

    Healthy control subjects who do not meet the criteria for the Postural Tachycardia Syndrome

    Device: Actigraphy Watch (motion sensors) with light sensors - ActiWatch from Minimitter
    Watch to be worn on wrist for 7 days (except in water) that will measure activity/movement.
    Other Names:
  • ActiWatch from Minimitter
  • Outcome Measures

    Primary Outcome Measures

    1. Sleep Latency [1 week]

    Secondary Outcome Measures

    1. Sleep Efficiency [1 week]

    2. Wake After Sleep Onset [1 week]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Diagnosed with orthostatic intolerance by the Vanderbilt Autonomic Dysfunction Center

    • Control subjects will be free of orthostatic intolerance and other major medical problems, free of medications during the study

    • Age between 18-65 years

    • Male and female subjects are eligible.

    • Able and willing to provide informed consent

    Exclusion Criteria:
    • Overt cause for postural tachycardia (such as acute dehydration)

    • Self-report of pregnancy

    • Inability to give, or withdrawal of, informed consent

    • Other factors which in the investigator's opinion would prevent the subject from completing the protocol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vanderbilt University Nashville Tennessee United States 37232-2195

    Sponsors and Collaborators

    • Satish R. Raj
    • National Center for Research Resources (NCRR)

    Investigators

    • Principal Investigator: Satish R Raj, MD MSCI, Vanderbilt University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Satish R. Raj, Assistant Professor of Medicine & Pharmacology, Vanderbilt University Medical Center
    ClinicalTrials.gov Identifier:
    NCT00692471
    Other Study ID Numbers:
    • 080233
    • K23RR020783
    First Posted:
    Jun 6, 2008
    Last Update Posted:
    Sep 8, 2021
    Last Verified:
    Sep 1, 2021
    Keywords provided by Satish R. Raj, Assistant Professor of Medicine & Pharmacology, Vanderbilt University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 8, 2021